Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−220.4x

Market Cap

$265.49M

MomentumView details →

1D Return

+0.00%

YTD Return

+1.98%

RSI (14)

54.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−220.4x

Market Cap

$265.49M

RSI (14)

54.6

MomentumView details →

1D Return

+0.00%

YTD Return

+1.98%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

3.41%

ROA (TTM)

3.27%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+43.05%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+453.51%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.73x

Quick Ratio

0.73x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

6.75M

Op. CF (TTM)

−455689.00

Latest newsMore news →

No recent news for OACC.

Similar companies

Blue Water Acquisition Corp IIIBLUWU Renatus Tactical Acquisition Corp IRTACU Newbury Street II Acquisition CorpNTWO A Paradise Acquisition Corp.APADU Launch One Acquisition Corp. UnitLPAAU Drugs Made In America Acquisition Corp. Ordinary SharesDMAA Find similar companies →

Latest newsMore news →

No recent news for OACC.